ARCHIVES

FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy

This article is from The Cancer Letter archive.

Vol. 30 No. 10 | October 26, 2007

Download PDF Visit The Full Archive

Related Articles

“Wild West” of Molecular Testing?: Caris Engaged in Aggressive Marketing, Improper Medicare Billing, Lawsuit Alleges

August 8, 2014

Investigators Testing Ways To Overcome Gleevec Resistance: High Dose, New Drugs

January 28, 2005

The Lancet Oncology Retracts Potti Paper, NEJM Doesn’t

February 4, 2011

NIH Not Proactive, Healy Tells NCAB ‘Beset’ By Issues

February 12, 1993

Denman Hammond, NCCF Founder, Receives Award.

November 17, 2000

New Drug Combination Shrinks Kidney Cancers

June 30, 2006